Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron

Amgen’s high-profile PCSK9 patent fight with Sanofi and Regeneron has attracted a who’s who of biopharma observers over the years, with many top companies voicing support for each side. Now, Amgen has suffered its third consecutive loss in the case.